Riders · Health and Human Services Commission · Article II: Health and Human Services

Clear Process for Including Prescription Drugs on the Texas Drug Code Index

Rider 152 in the 2024-25 Act, page II-99

This rider is not in the Introduced (Senate) or any later version.

Through the session

  1. 2024-25 Act In current law rider 152
  2. Introduced (Senate) Dropped
  3. Introduced (House) Not in this version
  4. Senate substitute Not in this version
  5. House substitute Not in this version
  6. House passed Not in this version
  7. Conference Not in this version
  8. 2026-27 Act Not in this version

Pick any two steps to compare their wording.

Every version: numbers, statuses and source pages
VersionRider Against the version beforeAgainst the current budget Source
2024-25 ActGeneral Appropriations Act, 2024-25 Biennium 152 First version — Page II-99
Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) Not in this version
Introduced (House)House Bill 1 as introduced (LBB recommended, House) Not in this version
Senate substituteCommittee Substitute for Senate Bill 1 Not in this version
House substituteHouse Committee Substitute for Senate Bill 1 Not in this version
House passedSenate Bill 1 as passed the second house Not in this version
ConferenceConference Committee Report for Senate Bill 1 Not in this version
2026-27 ActGeneral Appropriations Act, 2026-27 Biennium Not in this version
Full text of each wording

2024-25 Act

Source, page II-99

Clear Process for Including Prescription Drugs on the Texas Drug Code Index. The Health and Human Services Commission (HHSC) shall make clear their process for the inclusion of prescription drugs in the Medicaid and Children's Health Insurance Programs. In maintaining the prescription drug inclusion process, HHSC shall ensure that the timeline for review, including initiation of drug review, clinical evaluation, rate setting, Legislative Budget Board notification, and making the product available, does not extend past the 90th day of receipt of the completed application for coverage on the Texas Drug Code Index. After the applicable Drug Utilization Review Board meeting and approval by the HHSC Executive Commissioner, HHSC will complete the public posting of medical policies associated with the product.